# Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status

> **NCT01931527** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 31 (actual)

## Conditions studied

- Obesity
- Metabolic Syndrome
- Hyperuricemia

## Interventions

- **DRUG:** Rasburicase

## Key facts

- **NCT ID:** NCT01931527
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-06
- **Final completion:** 2012-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01931527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01931527, "Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01931527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*